Status:
COMPLETED
Fluvastatin in the Therapy of Acute Coronary Syndrome
Lead Sponsor:
Novartis
Collaborating Sponsors:
Ministry of Health, Czech Republic
Conditions:
Coronary Disease
Myocardial Infarction
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.
Eligibility Criteria
Inclusion
- Acute coronary syndrome
- Adults, 18 years and older
Exclusion
- History of lipid lowering therapy less than 30 days before index event
- Pregnancy and nursing
- Subject younger than 18 years
- Other inclusion and exclusion criteria may apply.
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00171275
Start Date
November 1 2003
Last Update
July 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Prague, Czechia